More on WST
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $312.17 |
|
|||
| Open | $313.47 | ||||
| 52 Wk High | $84.33 | ||||
| 52 Wk Low | $53.88 | ||||
| Day High | $317.56 | ||||
| Day Low | $309.88 | ||||
| P/E | 201.47 | ||||
| EPS | $1.57 | ||||
| Volume | 635,882 | ||||
- Jefferies finds AI drives up to 50% cost cuts in drug development
- Form 8-K WEST PHARMACEUTICAL SERV For: May 31
- West Pharmaceutical Services names Michel Lagarde as new CEO
- West Appoints Michel Lagarde to be President and Chief Executive Officer
- Wolfe Research Assumes West Pharmaceutical (WST) at Outperform
- Form 8-K/A WEST PHARMACEUTICAL SERV For: May 07
- West Pharmaceutical Services ramps production following cyberattack
- Form 4 WEST PHARMACEUTICAL SERV For: May 12 Filed by: Campbell Shane Alden
- Form SD WEST PHARMACEUTICAL SERV
- Form 8-K WEST PHARMACEUTICAL SERV For: May 07
Entities mentioned with WST
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Stock Buyback | View Related Stories »
- Show More...
